Related Experiment Video
Updated: Jan 11, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
From Teratoma to Pacemaker: A Rare Case of Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) Encephalitis With Severe
Mohamad A Bahrou1, Samie Gilani1, Mohamed R Labedi2
1Internal Medicine, Southern Illinois University School of Medicine, Springfield, USA.
Abstract:
We report a rare case of an 18-year-old female patient who presented with fever, altered mental status, and seizures and was diagnosed with anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis in the setting of a right ovarian teratoma with high-titer antibodies. Despite immunotherapy and tumor resection, she developed severe autonomic instability characterized by recurrent bradycardia, sinus pauses, and an episode of asystole, necessitating temporary transvenous pacing followed by permanent pacemaker (Boston Scientific, USA) implantation. This case highlights the potential for life-threatening cardiac complications in anti-NMDAR encephalitis and emphasizes the need for continuous cardiac monitoring, timely intervention, and multidisciplinary management.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013